BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 9171936)

  • 1. Evidence for a functional kit receptor in melanoma, breast, and lung carcinoma cells.
    DiPaola RS; Kuczynski WI; Onodera K; Ratajczak MZ; Hijiya N; Moore J; Gewirtz AM
    Cancer Gene Ther; 1997; 4(3):176-82. PubMed ID: 9171936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of the c-kit and stem cell factor genes in breast carcinomas.
    Hines SJ; Organ C; Kornstein MJ; Krystal GW
    Cell Growth Differ; 1995 Jun; 6(6):769-79. PubMed ID: 7545433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
    Krystal GW; Hines SJ; Organ CP
    Cancer Res; 1996 Jan; 56(2):370-6. PubMed ID: 8542594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
    Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
    Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias.
    Caceres-Cortes JR; Alvarado-Moreno JA; Waga K; Rangel-Corona R; Monroy-Garcia A; Rocha-Zavaleta L; Urdiales-Ramos J; Weiss-Steider B; Haman A; Hugo P; Brousseau R; Hoang T
    Cancer Res; 2001 Aug; 61(16):6281-9. PubMed ID: 11507083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of growth of human breast carcinoma cells by an antisense oligonucleotide targeted to the transferrin receptor gene.
    Yang DC; Jiang XP; Elliott RL; Head JF
    Anticancer Res; 2001; 21(3B):1777-87. PubMed ID: 11497259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
    Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
    Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.
    Welker P; Schadendorf D; Artuc M; Grabbe J; Henz BM
    Br J Cancer; 2000 Apr; 82(8):1453-8. PubMed ID: 10780526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
    Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
    Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential.
    Huang S; Luca M; Gutman M; McConkey DJ; Langley KE; Lyman SD; Bar-Eli M
    Oncogene; 1996 Dec; 13(11):2339-47. PubMed ID: 8957075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIT ligand (mast cell growth factor) inhibits the growth of KIT-expressing melanoma cells.
    Zakut R; Perlis R; Eliyahu S; Yarden Y; Givol D; Lyman SD; Halaban R
    Oncogene; 1993 Aug; 8(8):2221-9. PubMed ID: 7687762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
    Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible inhibition of IL-8 receptor B mRNA expression and proliferation in non-small cell lung cancer by antisense oligonucleotides.
    Olbina G; Cieslak D; Ruzdijic S; Esler C; An Z; Wang X; Hoffman R; Seifert W; Pietrzkowski Z
    Anticancer Res; 1996; 16(6B):3525-30. PubMed ID: 9042216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases.
    Tamborini E; Papini D; Mezzelani A; Riva C; Azzarelli A; Sozzi G; Pierotti MA; Pilotti S
    Br J Cancer; 2001 Aug; 85(3):405-11. PubMed ID: 11487273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
    Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
    J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
    Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
    Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introduction of the c-kit gene leads to growth suppression of a breast cancer cell line, MCF-7.
    Nishida K; Tsukamoto T; Uchida K; Takahashi T; Takahashi T; Ueda R
    Anticancer Res; 1996; 16(6B):3397-402. PubMed ID: 9042197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.